ScripsAmerica, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCRCQ research report →
Companywww.scripsamerica.com
ScripsAmerica, Inc. develops and sells non-sterile topical and transdermal pain creams. The company also provides pharmacy dispensing services for individual doctors, as well as billing and administrative services to independent pharmacies.
- CEO
- Brian Ettinger
- IPO
- 2012
- Employees
- 21
- HQ
- Clifton, NJ, US
Price Chart
Valuation
- Market Cap
- $14.11K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.19
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 89.44%
- Op Margin
- -12.34%
- Net Margin
- -15.33%
- ROE
- 162.57%
- ROIC
- 388.04%
Growth & Income
- Revenue
- $30.85M · 5447.50%
- Net Income
- $-4,731,046 · 57.74%
- EPS
- $-0.04 · 76.81%
- Op Income
- $-3,807,304
- FCF YoY
- 132.51%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -54.25
- Avg Volume
- 907.5
Get TickerSpark's AI analysis on SCRCQ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SCRCQ Coverage
We haven't published any research on SCRCQ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SCRCQ Report →